These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 11837498
1. Prader-Willi syndrome: how does growth hormone affect body composition and physical function? Carrel AL, Allen DB. J Pediatr Endocrinol Metab; 2001; 14 Suppl 6():1445-51. PubMed ID: 11837498 [Abstract] [Full Text] [Related]
2. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. Myers SE, Carrel AL, Whitman BY, Allen DB. J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820 [Abstract] [Full Text] [Related]
3. Early manifestations of Prader-Willi syndrome: influence of growth hormone. Eiholzer U, Schlumpf M, Nordmann Y, l'Allemand D. J Pediatr Endocrinol Metab; 2001 Jul; 14 Suppl 6():1441-4. PubMed ID: 11837497 [Abstract] [Full Text] [Related]
4. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome. Festen DA, de Lind van Wijngaarden R, van Eekelen M, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884 [Abstract] [Full Text] [Related]
5. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal. Allen DB, Carrel AL. J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076 [Abstract] [Full Text] [Related]
6. Benefits of long-term GH therapy in Prader-Willi syndrome: a 4-year study. Carrel AL, Myers SE, Whitman BY, Allen DB. J Clin Endocrinol Metab; 2002 Apr; 87(4):1581-5. PubMed ID: 11932286 [Abstract] [Full Text] [Related]
7. Growth hormone improves mobility and body composition in infants and toddlers with Prader-Willi syndrome. Carrel AL, Moerchen V, Myers SE, Bekx MT, Whitman BY, Allen DB. J Pediatr; 2004 Dec; 145(6):744-9. PubMed ID: 15580194 [Abstract] [Full Text] [Related]
8. Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database). Lindgren AC, Lindberg A. Horm Res; 2008 Dec; 70(3):182-7. PubMed ID: 18663319 [Abstract] [Full Text] [Related]
9. Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome. Höybye C. Acta Paediatr; 2007 Mar; 96(3):410-3. PubMed ID: 17407467 [Abstract] [Full Text] [Related]
10. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits. Myers SE, Whitman BY, Carrel AL, Moerchen V, Bekx MT, Allen DB. Am J Med Genet A; 2007 Mar 01; 143A(5):443-8. PubMed ID: 17103437 [Abstract] [Full Text] [Related]
11. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent. Carrel AL, Myers SE, Whitman BY, Allen DB. J Pediatr Endocrinol Metab; 2001 Mar 01; 14(8):1097-105. PubMed ID: 11592566 [Abstract] [Full Text] [Related]
12. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome. Höybye C, Thorén M, Böhm B. J Intellect Disabil Res; 2005 Apr 01; 49(Pt 4):245-52. PubMed ID: 15816811 [Abstract] [Full Text] [Related]
13. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study. Carrel AL, Myers SE, Whitman BY, Allen DB. J Pediatr; 1999 Feb 01; 134(2):215-21. PubMed ID: 9931532 [Abstract] [Full Text] [Related]
14. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. Fillion M, Deal C, Van Vliet G. J Pediatr; 2009 Feb 01; 154(2):230-3. PubMed ID: 18814886 [Abstract] [Full Text] [Related]
15. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome. Festen DA, Wevers M, Lindgren AC, Böhm B, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Clin Endocrinol (Oxf); 2008 Jun 01; 68(6):919-25. PubMed ID: 18031326 [Abstract] [Full Text] [Related]
16. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients. Höybye C, Hilding A, Marcus C, Thorén M. Growth Horm IGF Res; 2005 Dec 01; 15(6):411-5. PubMed ID: 16230042 [Abstract] [Full Text] [Related]
17. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome. Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Frystyk J, Christiansen JS, Höybye C. Growth Horm IGF Res; 2011 Aug 01; 21(4):185-90. PubMed ID: 21664161 [Abstract] [Full Text] [Related]
18. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome. Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C. Growth Horm IGF Res; 2010 Jun 01; 20(3):179-84. PubMed ID: 20199883 [Abstract] [Full Text] [Related]
19. Body composition during GH treatment in Prader-Labhardt-Willi syndrome. Bosio L, Beccaria L, Benzi F, Sanzari A, Chiumello G. J Pediatr Endocrinol Metab; 1999 Apr 01; 12 Suppl 1():351-3. PubMed ID: 10698601 [Abstract] [Full Text] [Related]
20. Body composition in Prader-Willi syndrome compared with nonsyndromal obesity: Relationship to physical activity and growth hormone function. van Mil EG, Westerterp KR, Gerver WJ, Van Marken Lichtenbelt WD, Kester AD, Saris WH. J Pediatr; 2001 Nov 01; 139(5):708-14. PubMed ID: 11713451 [Abstract] [Full Text] [Related] Page: [Next] [New Search]